CuraMedical B.V. of Assendelft at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair
Premium Exhibitor Manufacturers Trader OEM

CuraMedical B.V.

Industrieweg 13-1, 1566 JN Assendelft
Netherlands

Telephone +31 75 6571885
Fax +31 75 6571184
sales@curamedical.com

Hall map

MEDICA 2017 hall map (Hall 6): stand K34

Fairground map

MEDICA 2017 fairground map: Hall 6

Contact

Fred Hoogland

Director Marketing & Sales

Phone
+31756571885

Email
f.hoogland@curamedical.com

Eric van Walsteijn

Director Operations

Phone
+31756571885

Email
e.van.walsteijn@curamedical.com

Remco Tuenter

Sales Manager

Phone
+31756571885

Email
r.tuenter@curamedical.com

Patricia Garcia Rodriguez

Quality Regulatory Manager

Phone
+31756571885

Email
p.garcia-rodriguez@curamedical.com

Eric Hoogland

Quality Manager

Phone
+31756571885

Email
e.hoogland@curamedical.com

Berlinda Blom

Marketing & Sales / Stand Manager

Phone
+31756571885

Email
b.blom@curamedical.com

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.18  Dressings for wounds

Dressings for wounds

Our products

Product category: Haemostypticum

CuraSpon® - absorbable haemostatic gelatin sponge

Curaspon® is a sterile absorbable gelatin sponge with haemostatic effect suitable for the control of bleeding.
Curaspon® is manufactured from highly purified neutral gelatin foam of uniform fine porosity which guarantees a favourable haemostasis. The gelatin sponge activates the thrombocytes at the moment blood comes in contact with the matrix of the sponge. This causes thrombocytes to release a series of substances which promote their aggregation at the same time as their surfaces change character, thus enabling them to act as a catalyst for the formation of fibrin.
Curaspon® provides haemostasis in surgical procedures to control capillary, venous and small arterial bleeding when binding, suturing or other conventional methods of control are impractical or ineffective.
Curaspon® can be applied dry or moistened with sterile physiological saline. Curaspon® is pressed against the bleeding site and within a short time it will adhere to the wound and control the bleeding. It is recommended to remove any excess Curaspon® material from the operative field.

More Less

Product category: Haemostypticum

CuraCel® - absorbable haemostatic oxidized regenerated cellulose gauze

Oxidised Renegerated Cellulose Natural, plant based cellulose is dissolved and extruded as a continuous fibre (regeneration).
The fabric made from the fibre is very uniform in chemical composition and its oxidation results in less variation in stability and absorbility of the material compared to cotton based products. Curacel® Absorbable Haemostat is a sterile product made of oxidized regenerated cellulose (polyoxyan hydro glucuronic acid). The action mechanism of Curacel® is independent from the blood coagulation mechanism of the body. When it comes into contact with blood, Curacel® forms a brownish or black gelatinous mass which aids clot formation. This gelatinous mass acts as a physical matrix to which platelets can adhere. With platelet aggregation and formation of a platelet-fibrin plug, haemostatis occurs.
Curacel is available in standard knit, high density knit and fibrous fabric.

More Less

Product category: Haemostypticum

CuraTamp® - absorbable haemostatic oxidized cellulose gauze

Curatamp® is a sterile, absorbable haemostat made from Oxidised Cellulose. Oxidised Cellulose is a fabric material that is obtained by the oxidation of alpha grade cotton gauze using nitrous oxide. The low pH of the cellulosic acid within the product has caustic properties that lead to haemostasis via the initial denaturation of blood proteins. Curatamp® provides haemostasis in surgical procedures to control capillary, venous and small arterial bleeding when binding, suturing or other conventional methods of control are impractical or ineffective.

More Less

About us

Company details

CuraMedical BV is a Dutch medical device company that operates in the wound management sector and specialises in the development, manufacturing and marketing of haemostatic agents. Continuously striving to offer exceptional quality and value, the company uses leading-edge technology to ensure an outstanding and reliable product performance.

CuraMedical entered the healthcare market in 1995 with Curaspon®, an absorbable haemostatic agent based on pharmaceutical gelatin. The haemostatic product line was further developed with the introduction of Curacel®, a range of oxidised regenerated cellulose haemostats, and Curatamp®, an oxidised cellulose haemostat.

Nowadays our products are distributed in over 60 different countries worldwide. Since the start of the company, millions of haemostats have been used in clinical sites all over the world and we are continuing to expand and grow our market share. Product quality and performance have always been a priority across our organisation and thanks to our highly qualified and dedicated staff, we have maintained those standards and established ourselves as one of the major players in the wound management sector.

CuraMedical, we help you to cure people!


Quality
CuraMedical can rely on a substantial record of sales without reportable complaints or adverse incidents which has proven our product’s efficacy and performance. The quality management system of CuraMedical B.V. and further required documented procedures have been reviewed by the notified body MDC (CE 0483) with respect of the requirements of the Medical Device Directive 93/42/EEC, Annex II, and EN ISO 13485:2012.

More Less

Company data

Sales volume

1-9 Mio US $

Export content

> 75%

Number of employees

1-19

Foundation

1998

Area of business

Commodities and Consumer Good for Surgeries and Hospitals